Secor Capital Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-28,407
Closed -$632K 426
2018
Q2
$632K Buy
28,407
+3,830
+16% +$78.3K 0.05% 351
2018
Q1
$424K Sell
24,577
-62,711
-72% -$1.05M 0.03% 388
2017
Q4
$1.45M Sell
87,288
-8,574
-9% -$146K 0.06% 240
2017
Q3
$1.64M Buy
95,862
+45,127
+89% +$758K 0.16% 208
2017
Q2
$822K Buy
50,735
+1,055
+2% +$16.7K 0.07% 299
2017
Q1
$862K Buy
49,680
+12,044
+32% +$201K 0.09% 267
2016
Q4
$635K Buy
+37,636
New +$628K 0.08% 301
2016
Q3
Sell
-36,017
Closed -$517K 504
2016
Q2
$517K Buy
36,017
+11,296
+46% +$141K 0.07% 394
2016
Q1
$304K Buy
+24,721
New +$273K 0.04% 432
2014
Q4
Sell
-21,562
Closed -$296K 384
2014
Q3
$296K Sell
21,562
-6,432
-23% -$91.8K 0.17% 219
2014
Q2
$457K Buy
27,994
+12,759
+84% +$185K 0.24% 146
2014
Q1
$240K Sell
15,235
-4,471
-23% -$72.8K 0.12% 250
2013
Q4
$339K Buy
+19,706
New +$303K 0.14% 247

Other funds holding ANGO

Secor Capital Advisors's ANGO Position: Q3 2018 in Review

Secor Capital Advisors sold out of AngioDynamics (ANGO) in Q3 2018, closing a stake of 28,407 shares — an estimated $632K sold.

Secor Capital Advisors first reported a position in ANGO in Q4 2013 and held it in 13 quarters. The position peaked at $1.64M in Q3 2017. 177 funds tracked by Wall St. Rank hold ANGO as of Q3 2018.

  • Secor Capital Advisors reported no remaining AngioDynamics position as of Q3 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 28,407 AngioDynamics shares in Q3 2018, an estimated $632K.
  • Secor Capital Advisors first reported a position in AngioDynamics in Q4 2013 and held it in 13 quarters.
  • Secor Capital Advisors's AngioDynamics position peaked at $1.64M in Q3 2017.
  • 177 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.